SEMA – Semaglutide 2 mg

39,90 

In stock

  • *Quantity in package

SEMA – Semaglutide 2mg are tested and have required amount of substance of highest quality:

» Test results of our Semaglutide 2mg

Semaglutide 2 mg is a high-purity lyophilized research peptide supplied in a sterile glass vial containing 2 mg of active compound per vial. Semaglutide is a potent GLP-1 receptor agonist widely studied in metabolic and endocrinology research. This product is intended strictly for laboratory and scientific research use only.

Reconstitute:
Add 1.0 mL bacteriostatic water → 5.0 mg for optimal concentration.
Storage after reconstitution:
refrigerate at 2-8 °C and use up to 4 weeks.

SKU: SEMA2 Category: Brand:

SEMA – Semaglutide 2mg are tested and have required amount of substance of highest quality:

» Test results of our Semaglutide 2mg

Semaglutide 2 mg is a high-purity lyophilized research peptide supplied in a sterile glass vial containing 2 mg of active compound per vial. Semaglutide is a potent GLP-1 receptor agonist widely studied in metabolic and endocrinology research. This product is intended strictly for laboratory and scientific research use only.

Reconstitute:
Add 1.0 mL bacteriostatic water → 5.0 mg for optimal concentration.
Storage after reconstitution:
refrigerate at 2-8 °C and use up to 4 weeks.

What are the benefits of Semaglutide?

01 Weight management

Semaglutide is widely recognized for supporting significant weight loss and long-term weight maintenance. It is approved to help reduce excess body weight and maintain weight reduction over time when combined with a reduced-calorie diet and increased physical activity.

02 Improved blood sugar control

Semaglutide helps improve glycemic control in adults with type 2 diabetes. It supports better blood sugar regulation and also slows early post-meal gastric emptying, which can help reduce postprandial glucose spikes.

03 Reduced appetite and calorie intake

One of Semaglutide’s key advantages is its effect on appetite regulation. Clinical research has shown that it can reduce energy intake, increase satiety and fullness, improve eating control, and lower hunger and preference for energy-dense foods.

04 Cardiovascular support

Semaglutide has demonstrated cardiovascular benefits in appropriate patient groups. It is approved to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes and established cardiovascular disease, and Wegovy is also approved to reduce cardiovascular risk in adults with established cardiovascular disease and overweight or obesity.

05 Kidney health support

Semaglutide also offers kidney-related benefits in adults with type 2 diabetes and chronic kidney disease. The Ozempic label includes reduction of the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death in this population.

06 Liver health benefits

Semaglutide is also associated with liver-related benefits. Wegovy is approved for adults with noncirrhotic MASH with moderate to advanced fibrosis, and clinical trials have shown improved liver histologic outcomes in patients with MASH/NASH.

Lyophilized investigational peptide

Semaglutide 2 mg

Semaglutide 2 mg is a premium-grade lyophilized investigational peptide supplied in a sterile glass vial containing 2 milligrams per vial. Semaglutide selectively targets the GLP-1 (Glucagon-Like Peptide-1) receptor, which is a key regulator of metabolic signaling pathways.

This peptide is extensively studied in preclinical and research laboratory settings for its effects on glucose metabolism, energy balance, and related endocrine pathways. Semaglutide is intended strictly for laboratory research and scientific investigation and is not approved for human or clinical use.

Mechanism of Action

Semaglutide is engineered to selectively activate GLP-1 receptors, which are involved in:

• Glucose-dependent insulin signaling
• Appetite regulation and satiety research
• Metabolic pathway modulation

This receptor-selective activity makes Semaglutide a widely used tool in laboratory research exploring endocrine and metabolic processes.

Research Applications

Semaglutide 2 mg is commonly used in laboratory research for:

• Glucose metabolism studies
• Insulin sensitivity research
• Appetite and energy balance modeling
• Obesity-related metabolic pathway research
• Endocrinology laboratory experiments
• Receptor binding and signaling analysis
• Dose-response laboratory evaluations

Its receptor-specific activity allows researchers to study GLP-1 mediated metabolic effects in a controlled environment.

Scientific Context

GLP-1 receptor agonists, such as Semaglutide, are widely referenced in research for their ability to modulate metabolic pathways. The compound is especially relevant for studies examining incretin-based metabolic regulation and related endocrine mechanisms.

Semaglutide is considered a benchmark GLP-1 receptor agonist in metabolic research due to its high receptor specificity and well-characterized signaling profile.

Product Specifications

Product Name: Semaglutide
Content: 2 mg per vial
Form: Lyophilized powder
Grade: Research use only
Purity: High laboratory-grade purity
Packaging: Sterile sealed glass vial
Storage: Store refrigerated at 2–8°C

Stability and Handling

The lyophilized form ensures long-term stability under appropriate laboratory storage conditions.

Recommended laboratory handling:

• Store at 2–8°C
• Protect from light and moisture
• Avoid repeated freeze–thaw cycles
• Reconstitute under sterile laboratory conditions

Proper handling preserves structural integrity and ensures reliable experimental results.

Research Classification

Semaglutide is classified as an investigational peptide compound intended exclusively for:

• In vitro laboratory research
• Analytical testing
• Scientific experimentation
• Controlled research applications

It is not approved for therapeutic, diagnostic, veterinary, or human use.

Important Notice

This product is sold strictly for laboratory research purposes only.

It is not intended for human consumption, medical use, or clinical application. By purchasing this product, the buyer confirms that it will be used solely for lawful scientific research.

FAQ

FREQUENTLY ASKED QUESTIONS

Semaglutide is a GLP-1 receptor agonist. Unlike dual- or triple-agonist peptides, semaglutide works through the GLP-1 pathway only, helping to regulate appetite, food intake, and glucose control. Because it targets a single pathway, its profile is different from newer multi-agonist compounds.

SEMA comes in the form of a lyophilized powder in a glass vial. Before administration, the solution is prepared by adding 1 ml of bacteriostatic water (included in the package).

After mixing the lyophilized powder with bacteriostatic water, store it in a refrigerator at 2 to 8 °C and protect it from light. Use within 4 weeks of preparation (mixing the powder with bacteriostatic water). The lyophilized powder itself, in the glass vial, should also be stored in a refrigerator at the same temperature.

We accept payment by card, bank transfer, and cash on delivery. We ship via Packeta to Slovakia, the Czech Republic, Poland, Hungary, and Germany. Standard delivery time is up to 10 days. Shipping is free for orders over €100.

We provide customer support by email. We respond within 24 hours. You can contact us at the email address listed in the customer service contact details.

SEMA acts through targeted GLP-1 receptor activity.

Semaglutide 2 mg

Its mechanism is based on biological signaling pathways.

It is designed to engage the GLP-1 pathway involved in appetite regulation and food intake control. Rather than a multi-pathway profile, it reflects focused GLP-1 receptor activity associated with satiety support and metabolic regulation.